BioMarin Pharmaceutical Inc. (BMRN) to Present at the Goldman, Sachs & Co. Global Healthcare Conference
6/6/2013 9:17:59 AM
More...
|
BioMarin Pharmaceutical Inc. (BMRN) Initiates Phase 3 Trial for PEG-PAL for the Treatment of PKU
6/5/2013 9:28:02 AM
More...
|
BioMarin Pharmaceutical Inc. (BMRN) Provides Preliminary Data on Ongoing Phase 1/2 Trial for BMN 673 for the Treatment of Solid Tumors at 2013 American Society of Clinical Oncology Annual Meeting
6/3/2013 9:43:36 AM
More...
|
BioMarin Pharmaceutical Inc. (BMRN) to Present at the Jefferies and Co. Global Healthcare Conference
5/31/2013 9:52:06 AM
More...
|
BioMarin Pharmaceutical Inc. (BMRN) Release: FDA Accepts Vimizim BLA and Grants Priority Review Designation
5/30/2013 9:44:05 AM
More...
|
What Mystery $7 Billion Life Science Company is Moving to SF's Mission Bay? Is it Illumina, Inc. (ILMN)? BioMarin Pharmaceutical Inc. (BMRN)?
5/30/2013 7:46:00 AM
More...
|
BioMarin Pharmaceutical Inc. (BMRN) Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
5/20/2013 9:38:37 AM
More...
|
BioMarin Pharmaceutical Inc. (BMRN) Announces BMN-673 Data in Breast and Ovarian Cancers to be Released at American Society of Clinical Oncology
5/17/2013 9:15:56 AM
More...
|
BioMarin Pharmaceutical Inc. (BMRN) to Present at the UBS Global Healthcare Conference
5/14/2013 9:06:32 AM
More...
|
BioMarin Pharmaceutical Inc. (BMRN) Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
4/18/2013 11:25:44 AM
More...
|
|